TIF’s enriched Leaflet “The COVID-19 Pandemic & Haemoglobin Disorders“ is available today!

During these difficult and challenging times the coronavirus (COVID-19) pandemic is creating at a global level, individuals with underlying medical conditions, such as blood disorders, heart disease, chronic liver disease, endocrine disorders or patients with a compromised immune system, may face an increased risk of  COVID-19 infection, according to the US Centres for Disease Control & Prevention.

In view of above, the Thalassaemia International Federation (TIF), an international leader in educating and informing patients with thalassaemia and haemoglobin disorders, has developed and is now sharing with its global patients‘ community an informational leaflet about the new COVID-19 with a special focus to the challenges it presents for patients affected by thalassaemia and sickle cell disease (SCD).

The leaflet was compiled by Dr Androulla Eleftheriou, TIF Executive Director, and Dr Michael Angastiniotis, TIF Medical Advisor with the invaluable contribution of TIF’s International Advisory Panel Members, Dr Maria D. Cappellini, Professor of Haematology, Dr John Porter , Professor of Haematology, Dr Ali Taher, Professor of Haematology, Dr Antonio Piga, Professor of Paediatrics, Dr Paul Telfer, Consultant Haematologist, and Dr Perla Eleftheriou, Consultant Haematologist.

Τhe “COVID-19 Pandemic & Haemoglobin Disorders“ Leaflet is available in both English & Greek.

English

Greek